Pathstone Family Office’s Eastman Chemical EMN Stock Holding History

Pathstone Family Office’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$487K	Buy	6,338 +3,189	+101%	+$265K	﹤0.01%	1051
2023 Q2	$262K	Buy	3,149 +516	+20%	+$42K	﹤0.01%	1022
2023 Q1	$232K	Sell	2,633 -6,603	-71%	-$567K	﹤0.01%	1024
2022 Q4	$588K	Buy	9,236 +5,025	+119%	+$405K	0.01%	1019
2022 Q3	$300K	Buy	4,211 +1,823	+76%	+$164K	﹤0.01%	1223
2022 Q2	$214K	Buy	+2,388	New	+$247K	﹤0.01%	939
2021 Q1	–	Sell	-54	Closed	-$5K	–	865
2020 Q4	$5K	Buy	+54	New	+$5.01K	﹤0.01%	949
2019 Q3	–	Sell	-4,725	Closed	-$368K	–	649
2019 Q2	$368K	Hold	4,725	–	–	0.04%	147
2019 Q1	$358K	Buy	+4,725	New	+$376K	0.05%	136
2017 Q3	–	Sell	-1,950	Closed	-$164K	–	219
2017 Q2	$164K	Sell	1,950 -5	-0.3%	-$403	0.07%	115
2017 Q1	$158K	Buy	+1,955	New	+$154K	0.09%	109

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pathstone Family Office's EMN Position: Q3 2023 in Review

Pathstone Family Office increased its Eastman Chemical (EMN) stake by 101% in Q3 2023, buying an estimated $265K and bringing the position to 6,338 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Pathstone Family Office first reported a position in EMN in Q1 2017 and has held it in 11 quarters since. The position peaked at $588K in Q4 2022. 676 funds tracked by Wall St. Rank hold EMN as of Q3 2023.

Pathstone Family Office held 6,338 shares of Eastman Chemical worth $487K as of Q3 2023.
Pathstone Family Office bought 3,189 Eastman Chemical shares in Q3 2023, an estimated $265K.
Eastman Chemical made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1051 holding.
Pathstone Family Office first reported a position in Eastman Chemical in Q1 2017 and has held it in 11 quarters since.
Pathstone Family Office's Eastman Chemical position peaked at $588K in Q4 2022.
676 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.